Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5612386-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-oneMeSH

  a histamine H3 receptor inverse agonist; structure in first source

• C5746336-(4-(4-trifluoromethylphenyl)piperazine-1-yl)-9-(ribofuranosyl)-9H-purineMeSH

  has antineoplastic activity; structure in first source

• C5837196-(4-(5-fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl)pyridazine-3-carboxylic acid (2-cyclopropylethyl)amideMeSH

  structure in first source

• C5792576-(4-(aminomethyl)-2-chlorophenoxyl)benzo(c)(1,2)oxaborol-1(3H)-olMeSH

  has anti-inflammatory activity

• C5784566-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)(1,2,4)triazolo(4,3-a)pyridineMeSH

  an anti-arrhythmia agent that inhibits late sodium current; structure in first source

• C5708376-(4-chlorobutyl)-5-hydroxy-4-(phenylthio)-1-tosyl-5,6-dihydropyridine-2(1H)-oneMeSH

  inhibits glutamate release from synaptosomes

• C5614326-(4-chlorophenyl)-4-methyl-6H-pyrazolo(3,4-c)isothiazol-3-amineMeSH

  has antidermatophytic activity; structure in first source

• C5863346-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-2-(3-(trifluoromethylthio)phenylamino)-3,6-dihydropyrimidin-1-iumMeSH

  structure in first source

• C5708016-(4-chlorophenyl)-7H-(1,3)dioxolo(4,5-f)indol-7-one-5-oxideMeSH

  structure in first source

• C5683586-(4-chlorophenylsulfanyl)-2,4-hexadienoic acid hydroxyamideMeSH
• C5696696-(4-hydroxy-3-(trifluoromethyl)phenyl)-1-naphtholMeSH

  inhibits 17beta-hydroxysteroid dehydrogenase type 2; structure in first source

• C5723236-(4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-oneMeSH

  a phosphodiesterase 9 inhibitor with cognitive enhancing activity; a nootropic agent

• C5720116-(4-nitrobenzyl)-1-oxa-4,7,10-triazacyclododecane-N,N'',N'''-triacetic acidMeSH

  a chelating agent; structure in first source

• C5793776-(5-acetyl-2-methoxyphenyl)apigeninMeSH

  from Selaginella uncinata; structure in first source

• C5875436-(5-chloro-2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrileMeSH

  a survivin modulator; structure in first source

• C5614996-(6-(1-methyl-1H-pyrazol-4-yl)imidazo(1,2-b)pyridazin-3-ylmethyl)quinolineMeSH

  a MET kinase inhibitor; structure in first source

• C5827776-(6-hydroxybenzo(d)thiazol-2'-yl)-2-(N,N-dimethylamino)naphthaleneMeSH

  a probe for amyloid-beta plaques; structure in first source

• C5768676-(7-methoxy-2-trifluoromethylpyrazolo(1,5-a)pyridin-4-yl)-5-methyl-4,5-dihydro-3-(2H)-pyridazinoneMeSH

  structure in first source

• C5838836-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinoneMeSH
• C5604536-(N-(dimethylamino)ethyl)aminobenzo(f)quinazolineMeSH

  has antineoplastic activity; structure in first source

• C5604526-(N-(dimethylamino)ethyl)aminobenzo(h)quinazolineMeSH

  has antineoplastic activity; structure in first source

• C5617116-(N-acetylcystein-S-yl)-2,4,5-trihydroxymethamphetamineMeSH

  structure in first source

• C5882646-(methylsulfonyl)-3-((4-(pyrrolidin-1-yl)piperindin-1-yl)methyl)-N-(2,2,2,-trifluoro-1-phenylethyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamideMeSH

  an antisense oligonucleotide; structure in first source

• C5744416-(nitrooxy)hexyl 2-(6-methoxynaphthalen-2-yl)propanoateMeSH

  a naproxen prodrug

• C5707826-(nitrooxy)hexyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoateMeSH

  a nitric oxide donor; structure in first source

• C5772466-(propan-2-yl)-3-methyl-morpholine-2,5-dioneMeSH

  structure in first source

• C5879636-(trifluoromethyl)phenanthridineMeSH

  structure in first source

• D0151206-AminonicotinamideMeSH

  A vitamin antagonist which has teratogenic effects.

• C5619876-C-alpha-arabinofuranosylapigeninMeSH

  from species of Primula.; structure in first source

• D0187506-Cyano-7-nitroquinoxaline-2,3-dioneMeSH

  A potent excitatory amino acid antagonist with a preference for non-NMDA iontropic receptors. It is used primarily as a research tool.

• D0151216-Ketoprostaglandin F1 alphaMeSH

  The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.

• C5752616-O-(9-(2-nitro-1H-imidazolyl)-8-fluoropropyl)glucopyranoseMeSH

  a radiosensitizing agent; structure in first source

• C5752606-O-(9-(2-nitro-1H-imidazolyl)-8-hydroxypropyl)glucopyranoseMeSH

  a radiosensitizing agent; structure in first source

• C5843626-O-acyl-beta-D-glucosyl-beta-sitosterolMeSH

  from the stem bark of Klainedoxa gabonensis; structure in first source

• C5858816-O-beta-D-glucopyranosyl-20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol-3-oneMeSH

  from the roots of Panax notoginseng; structure in first source

• C5784106-O-beta-D-glucopyranosyl-4-hydroxy-2-methoxychalconeMeSH

  structure in first source

• C5597176-O-galloyl-1,5-anhydroglucitolMeSH

  antidiabetic agent isolated from the Japanese red maple Acer pycnanthum; structure in first source

• C5692166-O-methyl-D-glycero-alpha-L-gluco-heptopyranoseMeSH

  from Campylobacter jejuni NCTC 11168; structure in first source

• C5756636-OH-11-O-hydroxyphenanthreneMeSH
• C5805996-OH-BDE-47MeSH

  hydroxylated BDE-47 metabolite; BDE - bromobiphenyl ether

• C5668036-Phosphogluconolactonase DeficiencyMeSH
• D0108326-PhytaseMeSH

  An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26.

• C5867086-acetonyl-5,6-dihydrosanguinarineMeSH

  has pro-inflammatory activity; isolated from Chelidonium majus; structure in first source

• C5703496-acetoxy-7-hydroxyroyleanoneMeSH

  an anti-inflammatory agent isolated from Taiwania cryptomerioides; structure in first source

• C5884036-acetyl-9-(3,4,5-trimethoxybenzyl)-9H-pyrido(2,3-b)indoleMeSH

  has antineoplastic activity; structure in first source

• C5742796-amino-1-benzyl-3-(3,5-dimethylbenzyl)uracilMeSH

  structure in first source

• C5877096-amino-2-iminopyridineMeSH

  structure in first source

• C5791806-amino-2-thiouracilMeSH

  structure in first source

• C5871446-amino-3-(3,5-dimethylbenzyl)-1-(4-picolyl)uracilMeSH

  structure in first source

• C5727526-amino-5-(benzylamino)uracilMeSH

  a pharmacological chaperone that improves oxidation of phenylalanine